Lonza Group Ltd
LONN: XSWX (CHE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 468.00 | Xcjqypk | Chtnspxpn |
Maintaining CHF 620 Fair Value Estimate for Narrow-Moat Lonza; Shares Undervalued
We maintain our fair value estimate of CHF 620 per share for narrow-moat Lonza. The outlook for Lonza is bright as drug manufacturing becomes more complex with biologics and cell and gene therapies playing larger roles. We view Lonza’s share price as undervalued, currently trading 16% below our fair value estimate.